BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/29/2014 7:34:00 PM | Browse: 1466 | Download: 1191
Publication Name World Journal of Gastroenterology
Manuscript ID 6877
Country/Territory Italy
Received
2013-10-29 18:09
Peer-Review Started
2013-10-30 14:56
To Make the First Decision
2014-01-09 15:42
Return for Revision
2014-02-17 10:40
Revised
2014-02-19 06:49
Second Decision
2014-06-05 10:33
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-05 11:15
Articles in Press
2014-06-05 11:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-10-17 20:27
Publish the Manuscript Online
2014-10-29 19:34
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Clinical management of advanced gastric cancer: The role of new molecular drugs
Manuscript Source Invited Manuscript
All Author List Ferdinando De Vita, Natale Di Martino, Alessio Fabozzi, Maria Maddalena Laterza, Jole Ventriglia, Beatrice Savastano, Angelica Petrillo, Valentina Gambardella, Vincenzo Sforza, Luigi Marano, Annamaria Auricchio, Gennaro Galizia, Fortunato Ciardiello and Michele Orditura
Funding Agency and Grant Number
Corresponding Author Dr. Ferdinando De Vita, MD, PhD, Assistant Professor of Oncology, Division of Medical Oncology, Department of Clinical and Experimental Medicine and Surgery, Second University of Naples School of Medicine, c/o Ⅱ Policlinico, Edificio 3, Via Pansini 5, 80131 Naples, Italy. ferdinando.devita@unina2.it
Key Words Advanced gastric cancer; Gastrointestinal cancer; Targeted therapy; Monoclonal antibodies; Tyrosine-kinase inhibitor; Gastric cancer
Core Tip In this article we review the actual “scenario” of targeted treatments in advanced gastric cancer, also focusing on the new agents in development,discussing their efficacy and potential applications in clinical practice.
Publish Date 2014-10-29 19:34
Citation De Vita F, Di Martino N, Fabozzi A, Laterza MM, Ventriglia J, Savastano B, Petrillo A, Gambardella V, Sforza V, Marano L, Auricchio A, Galizia G, Ciardiello F, Orditura M. Clinical management of advanced gastric cancer: The role of new molecular drugs. World J Gastroenterol 2014; 20(40): 14537-14558
URL http://www.wjgnet.com/1007-9327/full/v20/i40/14537.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i40.14537
Full Article (PDF) WJG-20-14537.pdf
Full Article (Word) WJG-20-14537.doc
Manuscript File 6877-Review.doc
Answering Reviewers 6877-Answering reviewers.pdf
Copyright License Agreement 6877-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 6877-Language certificate.pdf
Peer-review Report 6877-Peer reviews.pdf
Scientific Misconduct Check 6877-CrossCheck.jpg
Scientific Editor Work List 6877-Scientific editor work list.pdf